dc.contributor.author | Kemik, Özgür | |
dc.contributor.author | Purisa, Sevim | |
dc.contributor.author | Kemik, Ahu Sarbay | |
dc.contributor.author | Sumer, Aziz | |
dc.contributor.author | Demir, Ali | |
dc.contributor.author | Yavuz, Alpaslan | |
dc.contributor.author | Suvak, Burak | |
dc.contributor.author | Dulger, Ahmet Cumhur | |
dc.date.accessioned | 2021-03-02T20:28:07Z | |
dc.date.available | 2021-03-02T20:28:07Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Sumer A., Demir A., Kemik A. S. , Yavuz A., Suvak B., Dulger A. C. , Purisa S., Kemik Ö., "Serum vascular endothelial growth factor receptor-3 levels in patients with esophageal squamous cell cancer", ANNALI ITALIANI DI CHIRURGIA, cilt.88, sa.1, ss.20-25, 2017 | |
dc.identifier.issn | 0003-469X | |
dc.identifier.other | av_022b72d7-fd80-4a3a-8111-f09aef473657 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/7401 | |
dc.description.abstract | AIM: Esophageal cancer is one of the most aggressive tumors of the gastrointestinal tract. In this study, we quantified the serum vascular endothelial growth factor-3 (VEGFR-3) expression in patients with esophageal squamous cell carcinoma (ESCC) to evaluate the role of VEGFR-3 in ESCC. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | CERRAHİ | |
dc.title | Serum vascular endothelial growth factor receptor-3 levels in patients with esophageal squamous cell cancer | |
dc.type | Makale | |
dc.relation.journal | ANNALI ITALIANI DI CHIRURGIA | |
dc.contributor.department | Van Yüzüncü Yıl Üniversitesi , , | |
dc.identifier.volume | 88 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 20 | |
dc.identifier.endpage | 25 | |
dc.contributor.firstauthorID | 238772 | |